The AVENIO Tumor Tissue Targeted Kit is a 17 gene (81kb) pan-cancer assay that contains guideline-aligned biomarkers, including those identified by the U.S. National Comprehensive Cancer Network (NCCN).
Learn moreThe AVENIO Tumor Tissue Expanded Kit is a 77 gene (192kb) pan-cancer assay that contains 17 genes in the NCCN and other guidelines, plus 60 emerging biomarkers investigated in clinical trials.
Learn moreThe AVENIO Tumor Tissue Surveillance Kit is a 197 gene (198kb) pan-cancer assay that contains 17 genes in the NCCN and other guidelines, and an additional 180 genes that are specially optimized for longitudinal monitoring of tumor burden and detection of minimal residual disease in lung cancer and colorectal cancer.
Learn more